December 2016

Welcome to the PM Buzz with the latest headlines in personalized medicine and the latest news, content and events from the Diaceutics Group.
Latest News in Personalized and Precision Medicine

Google and Novartis won't be testing smart contact lenses this year after all read on...
Dual biomarker signature holds predictive promise for response to Anti-PD-L1 therapy in NSCLC read on...
Next generation sequencing-based oncology test designed to support therapy selection submitted for FDA approval read on...
Bristol-Myers Squibb, Enterome enter immuno-oncology collaboration for microbiome-derived biomarkers development read on...
iPANDA: A novel approach for precision medicine and drug discovery on gene expression data read on...
Drugmakers to FDA: Let us share off-label study data with payers read on...
Novartis gets speedy FDA review for Midostaurin read on...
Experts debate MDx industry impact of AMP v. Myriad three years after court's decision read on...
AbbVie's pan-genotypic hep C prospect shines in trials read on...
Roche launches imCORE, a global network of cancer immunotherapy centers of excellence read on...
NanoString, OHSU partner on myeloid gene expression panels read on...
FDA approves Nivolumab for SCCHN read on...
Bristol-Myers' Opdivo nets the first PhIII gastric cancer win for checkpoint inhibitors read on...
Illumina's new test for tumor profiling and CDx read on...
Immunoseek CR (CD8/PD-L1), a new assay toward precision immunotherapy read on...
FDA approves Ventana PDL1 for NSCLC read on...
Selzentry approved for pediatric use read on...
These researchers think they have a solution to the global crisis in drug prices read on...
RedHill Biopharma provides update on ongoing Phase III and Phase II studies with BEKINDA and expected timing of top-line results read on...
Pfizer dumps PCSK9 inhibitor bococizumab after finding 'no value' in med read on...
Takeda CEO says new myeloma drug Ninlaro will be 'significantly bigger than Velcade' read on...
llumina submits companion Dx to FDA read on...
Monitoring MM patients using circulating tumor cells read on...
Big drop in prostate biopsies, prostatectomies in US read on...
Myriad moving ahead with PMA filing for MyChoice HRD as companion test for Niraparib read on...
Fast Company Innovation Festival asks, 'What's next for precision medicine?' read on...
Flatiron Health and Foundation Medicine unveil powerful oncology information resource to advance precision medicine read on...
Inivata and N-of-One partner to provide personalized genomic interpretation and clinical trial matching for cancer patients read on...
For first-line therapy of BRAF-mutant melanoma, PD-1 inhibitors may be preferred read on...
Corvus Pharmaceuticals announces biomarker fndings from Phase 1/1b study of lead oral checkpoint inhibitor CPI-444 at ESMO 2016 read on...
Peregrine Pharmaceuticals reports top-line and initial biomarker data from Phase III SUNRISE trial of Bavituximab in oral presentation at ESMO 2016 read on...
Myovant Sciences Ltd. announces pricing of initial public offering read on...
Astellas snaps up cancer antibody company Ganymed for up to $1.4bn read on...
Dako PD-L1 IHC 22C3 pharmDx receives expanded FDA approval in NSCLC read on...
Q2 Solutions enhances companion diagnostics capabilities in collaboration with Illumina read on...
Insurance plans dropping coverage of FDA-approved BRCA diagnostic test read on...
Johns Hopkins licenses microsatellite instability testing technology to PGDx read on...
Keytruda wins FDA approval in first line NSCLC read on...
UK plans 'fast track' for most cost-effective new medicines read on...
This month in Diaceutics news

[Webinar] Which Pharma Companies Are Ready For Precision Medicine in 2017? Benchmarking, Financial Risks and Predictions. December 14, 2016. read on...
[Ebook] The Challenges of Access and Reimbursement read on...
[Ebook] Regulatory Matters in Personalized Medicine read on...


     

© 2016 Diaceutics Group. All rights reserved.
Not interested? Unsubscribe | Update profile | Interested Subscribe | Impressed? Tell-A-Friend
Diaceutics | Belfast - New York